CS logo
small CS logo
Szpital Specjalistyczny nr 1 w Bytomiu

Bytom, Poland
Hospital in Bytom
Stefana Żeromskiego 7, 41-902 Bytom

About Szpital Specjalistyczny nr 1 w Bytomiu


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Shire
2
Allergan
1
Calliditas Therapeutics Suisse SA
1
Pfizer
1
Quark Pharmaceuticals
1
R-Pharm International, LLC
1
Vertex Pharmaceuticals Incorporated
1
Total Rows: 7

Clinical Trials at Szpital Specjalistyczny nr 1 w Bytomiu


During the past decade, Szpital Specjalistyczny nr 1 w Bytomiu conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3322000000001100001111221100Started TrialsCompleted Trails201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702
2005-06-01
2006-02-01
Completed
300
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
2012-02-01
2013-11-01
Completed
258
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-24
2019-11-05
Completed
1,648
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
2016-12-13
2017-06-13
Terminated
43
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate
2016-11-10
2018-08-15
Completed
269
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
2017-03-27
2019-05-13
Terminated
219
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
2017-03-29
2018-10-01
Completed
753
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
2022-02-14
2025-09-15
Recruiting
318

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Szpital Specjalistyczny nr 1 w Bytomiu" #1 sponsor was "Shire" with 2 trials, followed by "Allergan" with 1 trials sponsored, "Calliditas Therapeutics Suisse SA" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Quark Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Specjalistyczny nr 1 w Bytomiu" #1 collaborator was "OCT Clinical Trials" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsShire: 2Shire: 2Allergan: 1Allergan: 1Calliditas TherapeuticsSuisse SA: 1Calliditas TherapeuticsSuisse SA: 1Pfizer: 1Pfizer: 1Quark Pharmaceuticals: 1Quark Pharmaceuticals: 1R-Pharm International, LLC: 1R-Pharm International, LLC: 1Vertex PharmaceuticalsIncorporated: 1Vertex PharmaceuticalsIncorporated: 1

Created with Highcharts 11.1.0Top CollaboratorsOCT Clinical Trials: 1OCT Clinical Trials: 1Quintiles, Inc.: 1Quintiles, Inc.: 1

Clinical Trials Conditions at Szpital Specjalistyczny nr 1 w Bytomiu


According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny nr 1 w Bytomiu" are "Rheumatoid Arthritis" (3 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Choroidal Neovascularization" (1 trials) and "Diabetic Macular Edema" (1 trials). Many other conditions were trialed in "Szpital Specjalistyczny nr 1 w Bytomiu" in a lesser frequency.

Clinical Trials Intervention Types at Szpital Specjalistyczny nr 1 w Bytomiu


Most popular intervention types in "Szpital Specjalistyczny nr 1 w Bytomiu" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials), "AGN-195263" (1 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Szpital Specjalistyczny nr 1 w Bytomiu


The vast majority of trials in "Szpital Specjalistyczny nr 1 w Bytomiu" are 8 trials for "All" genders.

Clinical Trials Status at Szpital Specjalistyczny nr 1 w Bytomiu


Currently, there are NaN active trials in "Szpital Specjalistyczny nr 1 w Bytomiu". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Szpital Specjalistyczny nr 1 w Bytomiu, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Specjalistyczny nr 1 w Bytomiu, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 4Phase 2: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Terminated: 2Terminated: 2Recruiting: 1Recruiting: 1

Departments of Szpital Specjalistyczny nr 1 w Bytomiu


Szpital Specjalistyczny nr 1 w Bytomiu has several departments that took part in Clinical trials: "Szpital Specjalistyczny Nr 1 w Bytomiu, Oddzial Obserwacyjno-Zakazny i Hepatologii" - 2 trials, "Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji" - 2 trials